Chlorhexidine Mouth Rinse Market Report 2026

The chlorhexidine mouth rinse market size has grown strongly in recent years. It will grow from $1.08 billion in 2025 to $1.16 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing prevalence of periodontal disease, widespread use of antiseptic oral care, adoption in post-dental surgery protocols, availability of prescription oral rinses, expansion of dental clinic networks.

The chlorhexidine mouth rinse market size is expected to see strong growth in the next few years. It will grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing focus on preventive oral healthcare, rising demand for medicated home care products, expansion of otc therapeutic mouth rinses, growing preference for low-irritation formulations, increasing oral hygiene awareness. Major trends in the forecast period include increasing demand for alcohol-free mouth rinse formulations, growing use of post-surgical oral care products, rising preference for combination oral antiseptic solutions, expansion of prescription-based dental rinses, enhanced focus on long-term plaque control.

The increasing prevalence of oral diseases is anticipated to drive the growth of the chlorhexidine mouth rinse market in the coming years. Oral diseases encompass disorders of the mouth and oral cavity, such as tooth decay, gum infections, and other conditions impacting oral health. The surge in oral diseases is largely attributed to high sugar consumption, which fosters tooth decay and gum issues by nourishing harmful oral bacteria that produce acids eroding tooth enamel. Chlorhexidine mouth rinse aids in preventing and managing oral diseases by eliminating or suppressing the growth of harmful bacteria in the mouth, thereby reducing plaque formation, gingivitis, and the likelihood of infections. For example, in January 2025, the American Cancer Society, a U.S.-based professional organization, estimated that approximately 59,660 new cases of oral cavity and oropharyngeal cancer would be diagnosed in 2025, with around 12,770 deaths projected from these cancers. Consequently, the rising prevalence of oral diseases is fueling the growth of the chlorhexidine mouth rinse market.

The growing healthcare expenditure is expected to support the expansion of the chlorhexidine mouth rinse market in the near future. Healthcare expenditure refers to the resources allocated for the prevention, diagnosis, treatment, and management of diseases and health conditions. The increase in healthcare spending is driven by the growing prevalence of chronic illnesses, which necessitate continuous medical care and treatment. Rising healthcare expenditure enhances accessibility to chlorhexidine mouth rinse by funding its production, distribution, and integration into dental care programs, ensuring effective prevention and treatment of oral infections. For instance, in December 2024, the Centers for Medicare & Medicaid Services, a U.S.-based agency responsible for Medicare and Medicaid, reported that U.S. healthcare expenditures in 2023 grew by 7.5%, reaching $4.9 trillion, or about $14,570 per person. Therefore, the increase in healthcare expenditure is driving the growth of the chlorhexidine mouth rinse market.

The development of dental care infrastructure is anticipated to stimulate the growth of the chlorhexidine mouth rinse market moving forward. Dental care infrastructure refers to the availability of facilities, technologies, workforce, and healthcare systems that facilitate the prevention, diagnosis, and treatment of oral health issues. The growth of dental care infrastructure is fueled by rising awareness of oral health, which heightens demand for preventive and advanced dental services. Well-developed dental care infrastructure supports the use of chlorhexidine mouth rinse by providing trained professionals and properly equipped facilities to recommend, dispense, and monitor its use in preventing oral infections. For example, in January 2024, the British Dental Association (BDA), a UK-based professional association and trade union for dentists, noted in the Department of Health and Social Care’s 2022/23 report and annual accounts that £2.899 billion ($3.97 billion) was allocated to NHS dentistry spending. Therefore, the expansion of dental care infrastructure is propelling the growth of the chlorhexidine mouth rinse market.

Major companies operating in the chlorhexidine mouth rinse market are Procter & Gamble, GlaxoSmithKline plc, 3M Company, Medline Inc., Colgate-Palmolive Company, Teva Pharmaceutical Industries Ltd., Viatris Inc., Ecolab Inc., Henry Schein Inc., Perrigo Company plc, Dentsply Sirona, Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Sunstar Suisse S.A., Xttrium Laboratories, Young Innovations Inc., Hager & Werken, Curaden AG, ICPA Health Products Ltd., Arvoni Lifesciences Private Limited, AstraEureka Pharmaceuticals, Topcaredent AG.

Tariffs are influencing the chlorhexidine mouth rinse market by increasing costs of imported active pharmaceutical ingredients, formulation excipients, packaging materials, and bottling equipment. Pharmaceutical manufacturers and dental product suppliers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on export-oriented oral care production. These tariffs are raising manufacturing and retail prices. However, they are also encouraging domestic api production, localized formulation facilities, and regional expansion of oral healthcare manufacturing capabilities.

The chlorhexidine mouth rinse market research report is one of a series of new reports that provides chlorhexidine mouth rinse market statistics, including chlorhexidine mouth rinse industry global market size, regional shares, competitors with a chlorhexidine mouth rinse market share, detailed chlorhexidine mouth rinse market segments, market trends and opportunities, and any further data you may need to thrive in the chlorhexidine mouth rinse industry. This chlorhexidine mouth rinse market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Chlorhexidine mouth rinse is a therapeutic oral solution that contains chlorhexidine gluconate, a powerful antiseptic that reduces oral bacteria, dental plaque, and gingival inflammation. It is widely used in routine dental care and after oral or dental surgeries to lower the risk of infection. The rinse supports oral hygiene maintenance, helps control plaque buildup and gum disease, and aids in preventing oral infections.

The primary product types of chlorhexidine mouth rinses include alcohol-based and alcohol-free formulations. Alcohol-based mouth rinses refer to antiseptic oral rinses containing alcohol that help reduce oral bacteria, prevent plaque formation, and maintain oral hygiene. These products are available in concentrations such as 0.12%, 0.20%, and other concentrations. They are applied across areas including dental care, oral surgery, periodontal disease, and other applications. They are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels, and are used by end users including hospitals, dental clinics, home care, and other end users.

The chlorhexidine mouth rinse market consists of sales of chlorhexidine gels, chlorhexidine sprays, chlorhexidine lozenges, combination oral care products, medicated rinse solutions, prescription and over-the-counter formulations, and related dental hygiene products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.